Hu Y - Search Results

1

Breath profile as composite biomarkers for lung cancer diagnosis.

Zou Y, Wang Y, Jiang Z, Zhou Y, Chen Y, Hu Y, Jiang G, Xie D. Zou Y, et al. Among authors: hu y. Lung Cancer. 2021 Apr;154:206-213. doi: 10.1016/j.lungcan.2021.01.020. Epub 2021 Jan 30. Lung Cancer. 2021. PMID: 33563485

2

[Measurement of exhaled volatile organic compounds in lung cancer patients].

Lu CR, Hu YJ, Chen EG, Qiu YH, Ying KJ. Lu CR, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2010 Feb;33(2):104-8. Zhonghua Jie He He Hu Xi Za Zhi. 2010. PMID: 20367949 Chinese.

3

[Determination of volatile organic compounds in lung cancer cell lines and lung cancer tissue].

Hu YJ, Qiu YH, Chen EG, Ying KJ, Yu J, Wang P. Hu YJ, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 May;39(3):278-84. doi: 10.3785/j.issn.1008-9292.2010.03.011. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 20544990 Chinese.

4

The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.

Wang Y, Hu Y, Wang D, Yu K, Wang L, Zou Y, Zhao C, Zhang X, Wang P, Ying K. Wang Y, et al. Among authors: hu y. Cancer Biomark. 2012;11(4):129-37. doi: 10.3233/CBM-2012-00270. Cancer Biomark. 2012. PMID: 23144150

5

CEA, SCC and NSE levels in exhaled breath condensate--possible markers for early detection of lung cancer.

Zou Y, Wang L, Zhao C, Hu Y, Xu S, Ying K, Wang P, Chen X. Zou Y, et al. Among authors: hu y. J Breath Res. 2013 Dec;7(4):047101. doi: 10.1088/1752-7155/7/4/047101. Epub 2013 Nov 1. J Breath Res. 2013. PMID: 24185583

6

Optimization of volatile markers of lung cancer to exclude interferences of non-malignant disease.

Zou Y, Zhang X, Chen X, Hu Y, Ying K, Wang P. Zou Y, et al. Among authors: hu y. Cancer Biomark. 2014;14(5):371-9. doi: 10.3233/CBM-140418. Cancer Biomark. 2014. PMID: 25171479

7

Rational lung tissue and animal models for rapid breath tests to determine pneumonia and pathogens.

Zhou Y, Chen E, Wu X, Hu Y, Ge H, Xu P, Zou Y, Jin J, Wang P, Ying K. Zhou Y, et al. Among authors: hu y. Am J Transl Res. 2017 Nov 15;9(11):5116-5126. eCollection 2017. Am J Transl Res. 2017. PMID: 29218109 Free PMC article.

8

Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.

Wang M, Sheng J, Wu Q, Zou Y, Hu Y, Ying K, Wan H, Wang P. Wang M, et al. Among authors: hu y. J Breath Res. 2018 Sep 14;12(4):046013. doi: 10.1088/1752-7163/aad9cc. J Breath Res. 2018. PMID: 30102249

9

Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection.

Chen X, Muhammad KG, Madeeha C, Fu W, Xu L, Hu Y, Liu J, Ying K, Chen L, Yurievna GO. Chen X, et al. Among authors: hu y. Lung Cancer. 2021 Apr;154:197-205. doi: 10.1016/j.lungcan.2021.02.006. Epub 2021 Feb 14. Lung Cancer. 2021. PMID: 33653598

10

Exhaled metabolic markers and relevant dysregulated pathways of lung cancer: a pilot study.

Zou Y, Hu Y, Jiang Z, Chen Y, Zhou Y, Wang Z, Wang Y, Jiang G, Tan Z, Hu F. Zou Y, et al. Among authors: hu f, hu y. Ann Med. 2022 Dec;54(1):790-802. doi: 10.1080/07853890.2022.2048064. Ann Med. 2022. PMID: 35261323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,718 results

Search Page

Filters